ACOTEC SCIEN.H. DL-00001

Research ACOTEC SCIEN.H. DL-00001 (7W3) on Bullrun: market cap EUR 228.73M, P/E 14.2. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 228.73M; P/E is 14.2.

Peer valuation comparison

Latest P/E is 14.2x versus a Healthcare sector median of 24.46x (41.9% below).

Latest P/E is 14.2x versus a China median of 10.67x (33.0% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CNY 644.63MCNY 119.18MCNY 69.12M73.9%0.39CNY 399.82MCNY 244.39MCNY 1.48B
FY2024CNY 533.99MCNY 52.28MCNY 5.31M75.4%0.17CNY 751.39MCNY 202.92MCNY 1.35B
FY2023CNY 473.85MCNY 14.49M-CNY 92.54M79.6%0.05CNY 637.63MCNY 234.00MCNY 1.30B
FY2022CNY 395.55MCNY 70.14M-CNY 115.45M85.0%0.23CNY 986.46MCNY 47.78MCNY 1.28B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-14EUR 228.73M14.2n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About ACOTEC SCIEN.H. DL-00001

Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China and internationally. The company's products include AcoArt Orchid & Dhalia, a paclitaxel DCB used to prevent stenosis or occlusion in superficial femoral artery and popliteal artery for the treatment of lower extremity artery disease with a vascular interventional approach;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is ACOTEC SCIEN.H. DL-00001's market cap?

ACOTEC SCIEN.H. DL-00001's market capitalization is EUR 228.73M.

What is ACOTEC SCIEN.H. DL-00001's P/E ratio?

ACOTEC SCIEN.H. DL-00001's price-to-earnings (P/E) ratio is 14.2.

What does ACOTEC SCIEN.H. DL-00001 do?

Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China and internationally.